nafronyl has been researched along with Scleroderma, Systemic in 2 studies
Nafronyl: A drug used in the management of peripheral and cerebral vascular disorders. It is claimed to enhance cellular oxidative capacity and to be a spasmolytic. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1310) It may also be an antagonist at 5HT-2 serotonin receptors.
Scleroderma, Systemic: A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gaylarde, PM | 2 |
Tan, OT | 2 |
Sarkany, I | 2 |
2 other studies available for nafronyl and Scleroderma, Systemic
Article | Year |
---|---|
Blood flow changes with naftidrofuryl in systemic sclerosis and Raynaud's phenomenon.
Topics: Adult; Aged; Body Temperature Regulation; Female; Fingers; Forearm; Furans; Humans; Leg; Male; Middl | 1980 |
Effect of naftidrofuryl oxalate (praxilene) on peripheral circulation measured by calorimetry.
Topics: Adult; Body Temperature; Calorimetry; Female; Fingers; Furans; Humans; Injections, Intravenous; Male | 1978 |